Active Tuberculosis Clinical Trial
Official title:
Performances of Immunoassays Based on the Detection of Antibodies Directed Against Mycobacterium Tuberculosis Antigen for the Diagnosis of Active Tuberculosis in Adults
TB remains a health problem in France with about 5,000 new cases per year. Development of new screening tests is a priority for TB. The main objective of the study is to evaluate performances of innovative blood tests to identify active tuberculosis in adults patients living in low-prevalence country. Adult patients with possible TB from will be tested for the presence of antibodies directed against M. tuberculosis selected antigens. Positive and negative predictive values will be established based on TB culture results.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05048381 -
miRNA in Sweat, a Novel Digital Biomarker for Detection of Active Tuberculosis (TB)
|
||
| Completed |
NCT03271567 -
Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients
|
||
| Not yet recruiting |
NCT02512484 -
Improving the Detection of Active Tuberculosis in Accident and Emergency Departments
|
N/A | |
| Completed |
NCT01269268 -
Characterization and Evaluation of Diagnostic Biomarkers for Tuberculosis
|
||
| Completed |
NCT06408129 -
COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB)
|
||
| Completed |
NCT02042261 -
The Role of Therapeutic Drug Monitoring in Tuberculosis - a Pilot Study
|
N/A | |
| Active, not recruiting |
NCT05045391 -
Pulmonary Aspergillosis in Tuberculosis Patients
|
||
| Completed |
NCT04048018 -
Performance Evaluation of the VIDAS TB-IGRA Assay.
|
||
| Recruiting |
NCT02639936 -
New Generation IGRA in Immunocompromised Individuals
|
N/A |